Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress

Nucleic Acids Research

Volumn 42, Issue 10, 2014, Pages 6270-6285

  McDade, Simon S ^a   Patel, Daksha ^a   Moran, Michael ^a   Campbell, James ^b   Fenwick, Kerry ^b   Kozarewa, Iwanka ^b   Orr, Nicholas J ^b   Lord, Christopher J ^b   Ashworth, Alan A ^b   McCance, Dennis J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; PROTEIN MSH2; PROTEIN P53; PROTEIN P63; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CELLULAR STRESS RESPONSE; CHROMATIN IMMUNOPRECIPITATION; CISTROME; CONTROLLED STUDY; DDB2 GENE; DNA METABOLISM; DNA REPAIR; DNA STRAND BREAKAGE; FANCD2 GENE; GENE; GENE IDENTIFICATION; GENE MAPPING; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; MSH2 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAD51B GENE; RRM2B GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; XPC GENE;

BINDING SITES; CELLS, CULTURED; CISPLATIN; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DOXORUBICIN; GENOME, HUMAN; HUMANS; KERATINOCYTES; MUTAGENS; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84903208950     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku299     Document Type: Article

References (76)

1. McDade, S.S. and McCance, D.J. (2010) The role of p63 in epidermal morphogenesis and neoplasia. Biochem. Soc. Trans., 38, 223-228.
2. Murray-Zmijewski, F., Lane, D.P. and Bourdon, J.-C. (2006) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ., 13, 962-972.
3. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.T., Tabin, C., Sharpe, A., Caput, D., Crum, C. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
4. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S. and Bradley, A.S.S. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
5. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z. and Tainsky, M.A. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
6. Mills, A., Zheng, B., Wang, X., Vogel, H. and Roop, D. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713
7. Brunner, H.G., Hamel, B.C.J. and Bokhoven Hv, H.V. (2002) P63 gene mutations and human developmental syndromes. Am. J. Med. Genet., 112, 284-290.
8. el-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nat. Genet., 1, 45-49.
9. Riley, T., Sontag, E., Chen, P. and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell. Biol., 9, 402-412.
10. Scheffner, M., Takahashi, T., Huibregtse, J.M., Minna, J.D. and Howley, P.M. (1992) Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol., 66, 5100-5105.
11. Bulavin, D.V., Demidov, O.N., Saito, S., Kauraniemi, P., Phillips, C., Amundson, S.A., Ambrosino, C., Sauter, G., Nebreda, A.R., Anderson, C.W. et al. (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet., 31, 210-215.
12. Momand, J., Zambetti, G.P., Olson, D.C., George, D. and Levine, A.J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
13. Stransky, N., Egloff, A.M., Tward, A.D., Kostic, A.D., Cibulskis, K., Sivachenko, A., Kryukov, G.V., Lawrence, M.S., Sougnez, C., McKenna, A. et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science, 333, 1157-1160.
14. Buckley, N.E., Conlon, S.J., Jirstrom, K., Kay, E.W., Crawford, N.T., O'Grady, A., Sheehan, K., Mc Dade, S.S., Wang, C.-W., McCance, D.J. et al. (2011) The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer. Cancer Res., 71, 1933-1944.
15. Urist, M.J., Di Como, C.J., Lu, M.-L., Charytonowicz, E., Verbel, D., Crum, C.P., Ince, T.A., McKeon, F.D. and Cordon-Cardo, C. (2002) Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol., 161, 1199-1206.
16. Tucci, P.P., Agostini, M.M., Grespi, F.F., Markert, E.K.E., Terrinoni, A.A., Vousden, K.H.K., Muller, P.A.J.P., Dötsch, V.V., Kehrloesser, S.S., Sayan, B.S.B. et al. (2012) Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 109, 15312-15317.
17. Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M.B., Guzzardo, V. et al. (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell, 137, 87-98.
18. Muller, P.A.J., Caswell, P.T., Doyle, B., Iwanicki, M.P., Tan, E.H., Karim, S., Lukashchuk, N., Gillespie, D.A., Ludwig, R.L., Gosselin, P. et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell, 139, 1327-1341.
19. Lang, G.A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V.A., Parant, J.M., Valentin-Vega, Y.A., Terzian, T., Caldwell, L.C., Strong, L.C. et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell, 119, 861-872.
20. Deyoung, M.P. and Ellisen, L.W. (2007) p63 and p73 in human cancer: defining the network. Oncogene, 26, 5169-5183.
21. Schavolt, K.L. and Pietenpol, J.A. (2007) p53 and ΔNp63α differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene, 26, 6125-6132.
22. Rinn, J.L. and Huarte, M. (2011) To repress or not to repress: this is the guardian's question. Trends Cell Biol., 21, 344-353.
23. Brady, C.A., Jiang, D., Mello, S.S., Johnson, T.M., Jarvis, L.A., Kozak, M.M., Kenzelmann Broz, D., Basak, S., Park, E.J., McLaughlin, M.E. et al. (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell, 145, 571-583.
24. Truong, A.B., Kretz, M., Ridky, T.W., Kimmel, R. and Khavari, P.A. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev., 20, 3185-3197.
25. McDade, S.S., Patel, D. and McCance, D.J. (2011) p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels. J. Cell Sci., 124, 1635-1643.
26. McDade, S.S.S., Henry, A.E.A., Pivato, G.P.G., Kozarewa, I.I., Mitsopoulos, C.C., Fenwick, K.K., Assiotis, I.I., Hakas, J.J., Zvelebil, M.M., Orr, N.N. et al. (2012) Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res., 40, 7190-7206.
27. Shin, H., Liu, T., Manrai, A.K. and Liu, X.S. (2009) CEAS: cis-regulatory element annotation system. Bioinformatics, 25, 2605-2606.
28. Botcheva, K.K., McCorkle, S.R.S., McCombie, W.R.W., Dunn, J.J.J. and Anderson, C.W.C. (2011) Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle, 10, 4237-4249.
29. Smeenk, L., van Heeringen, S.J., Koeppel, M., Gilbert, B., Janssen-Megens, E., Stunnenberg, H.G. and Lohrum, M. (2011) Role of p53 serine 46 in p53 target gene regulation. PLoS One, 6, e17574.
30. Incassati, A., Patel, D. and McCance, D.J. (2006) Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene, 25, 2444-2451.
31. Supek, F., Bošnjak, M., Škunca, N. and Šmuc, T. (2011) REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One, 6, e21800.
32. Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
33. Schmidt, D., Wilson, M.D., Spyrou, C., Brown, G.D., Hadfield, J. and Odom, D.T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods, 48, 240-248.
34. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nussbaum, C., Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol, 9, R137.1-R137.9.
35. ENCODE Project Consortium (2011) A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol., 9, e1001046.
36. Edgar, R., Domrachev, M. and Lash, A.E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
37. Ross-Innes, C.S.C., Stark, R.R., Teschendorff, A.E.A., Holmes, K.A.K., Ali, H.R.H., Dunning, M.J.M., Brown, G.D.G., Gojis, O.O., Ellis, I.O.I., Green, A.R.A. et al. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature, 481, 389-393.
38. Robinson, J.T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G. and Mesirov, J.P. (2011) Integrative genomics viewer. Nat. Biotechnol., 29, 24-26.
39. Ji, X., Li, W., Song, J., Wei, L. and Liu, X.S. (2006) CEAS: cis-regulatory element annotation system. Nucleic Acids Res., 34, W551-W554.
40. Saldanha, A.J. (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics, 20, 3246-3248.
41. Machanick, P. and Bailey, T.L. (2011) MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics, 27, 1696-1697.
42. Liu, T., Ortiz, J.A., Taing, L., Meyer, C.A., Lee, B., Zhang, Y., Shin, H., Wong, S.S., Ma, J., Lei, Y. et al. (2011) Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol., 12, R83.1-R83.10
43. Emig, D., Salomonis, N., Baumbach, J., Lengauer, T., Conklin, B.R. and Albrecht, M. (2010) AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res, 38, W755-W762.
44. Dreszer, T.R., Karolchik, D., Zweig, A.S., Hinrichs, A.S., Raney, B.J., Kuhn, R.M., Meyer, L.R., Wong, M., Sloan, C.A., Rosenbloom, K.R. et al. (2011) The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res, 40, D918-D923.
45. Goecks, J., Nekrutenko, A., Taylor, J. and Galaxy Team (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol, 11, R86.1-R86.13.
46. Blankenberg, D., Kuster, Von, G., Coraor, N., Ananda, G., Lazarus, R., Mangan, M., Nekrutenko, A. and Taylor, J. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol., Chapter 19, Unit 19.10.1-19.10.21.
47. Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Van Calcar, S., Qu, C., Ching, K.A. et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet., 39, 311-318.
48. Ye, T., Krebs, A.R., Choukrallah, M.A., Keime, C., Plewniak, F., Davidson, I. and Tora, L. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res., 39, e35-e35.
49. Rosenbloom, K.R., Dreszer, T.R., Pheasant, M., Barber, G.P., Meyer, L.R., Pohl, A., Raney, B.J., Wang, T., Hinrichs, A.S., Zweig, A.S. et al. (2010) ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res., 38, D620-D625.
50. Agrawal, N., Frederick, M.J., Pickering, C.R., Bettegowda, C., Chang, K., Li, R.J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J. et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science, 333, 1154-1157.
51. Thurlow, J.K., Peña Murillo, C.L., Hunter, K.D., Buffa, F.M., Patiar, S., Betts, G., West, C.M.L., Harris, A.L., Parkinson, E.K., Harrison, P.R. et al. (2010) Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J. Clin. Oncol., 28, 2881-2888.
52. Pyeon, D., Newton, M.A., Lambert, P.F., den Boon, J.A., Sengupta, S., Marsit, C.J., Woodworth, C.D., Connor, J.P., Haugen, T.H., Smith, E.M. et al. (2007) Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res., 67, 4605-4619.
53. Fury, W., Batliwalla, F., Gregersen, P.K. and Li, W. (2006) Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf. Proc. IEEE Eng. Med. Biol. Soc., 1, 5531-5534.
54. Chacko, A.D., McDade, S.S., Chanduloy, S., Church, S.W., Kennedy, R., Price, J., Hall, P.A. and Russell, S.E.H. (2012) Expression of the SEPT9 i4 isoform confers resistance to microtubule-interacting drugs. Cell Oncol. (Dordr.), 35, 85-93.
55. Kouwenhoven, E.N., van Heeringen, S.J., Tena, J.J., Oti, M., Dutilh, B.E., Alonso, M.E., de la Calle-Mustienes, E., Smeenk, L., Rinne, T., Parsaulian, L. et al. (2010) Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet., 6, e1001065.
56. Koeppel, M., van Heeringen, S.J., Kramer, D., Smeenk, L., Janssen-Megens, E., Hartmann, M., Stunnenberg, H.G. and Lohrum, M. (2011) Crosstalk between c-Jun and TAp73alpha/beta contributes to the apoptosis-survival balance. Nucleic Acids Res., 39, 6069-6085.
57. Carroll, J.S., Meyer, C.A., Song, J., Li, W., Geistlinger, T.R., Eeckhoute, J., Brodsky, A.S., Keeton, E.K., Fertuck, K.C., Hall, G.F. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289-1297.
58. Tan, T. and Chu, G. (2002) p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol. Cell. Biol., 22, 3247-3254.
59. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y. and Nakamura, Y. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, 404, 42-49.
60. Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A. and Stiewe, T. (2013) Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Genet., 9, e1003726.
61. Timofeev, O., Schlereth, K., Wanzel, M., Braun, A., Nieswandt, B., Pagenstecher, A., Rosenwald, A., Elsässer, H.-P. and Stiewe, T. (2013) p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo. Cell Rep., 3, 1512-1525.
62. Menendez, D., Nguyen, T.-A., Freudenberg, J.M., Mathew, V.J., Anderson, C.W., Jothi, R. and Resnick, M.A. (2013) Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res., 15, 7286-7301.
63. Barlow, C., Brown, K.D., Deng, C.-X., Tagle, D.A. and Wynshaw-Boris, A. (1997) Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet., 17, 453-456.
64. Huang, Y., Sen, T., Nagpal, J., Upadhyay, S., Trink, B., Ratovitski, E. and Sidransky, D. (2008) ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle, 7, 2846-2855.
65. Kurz, E.U., Douglas, P. and Lees-Miller, S.P. (2004) Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem., 279, 53272-53281.
66. Aksoy, O., Chicas, A., Zeng, T., Zhao, Z., McCurrach, M., Wang, X. and Lowe, S.W. (2012) The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev., 26, 1546-1557.
67. Antonini, D., Rossi, B., Han, R., Minichiello, A., Di Palma, T., Corrado, M., Banfi, S., Zannini, M., Brissette, J.L. and Missero, C. (2006) An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer. Mol. Cell. Biol., 26, 3308-3318.
68. Li, M.M., He, Y.Y., Dubois, W.W., Wu, X.X., Shi, J.J. and Huang, J.J. (2012) Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol. Cell, 46, 30-42.
69. Liu, Y.-Y., Patwardhan, G.A., Bhinge, K., Gupta, V., Gu, X. and Jazwinski, S.M. (2011) Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Cancer Res., 71, 2276-2285.
70. Lin, Y.-L., Sengupta, S., Gurdziel, K., Bell, G.W., Jacks, T., Flores, E.R. and Ford, J.M. (2009) p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet., 5, e1000680-e1000680.
71. Nikulenkov, F.F., Spinnler, C.C., Li, H.H., Tonelli, C.C., Shi, Y.Y., Turunen, M.M., Kivioja, T.T., Ignatiev, I.I., Kel, A.A., Taipale, J.J. et al. (2012) Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ., 19, 1992-2002.
72. Ramsey, M.R., Wilson, C., Ory, B., Rothenberg, S.M., Faquin, W., Mills, A.A. and Ellisen, L.W. (2013) FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J. Clin. Invest., 123, 3525-3538.
73. Gallant-Behm, C.L., Ramsey, M.R., Bensard, C.L., Nojek, I., Tran, J., Liu, M., Ellisen, L.W. and Espinosa, J.M. (2012) ΔNp63α represses anti-proliferative genes via H2A.Z deposition. Genes Dev., 26, 2325-2336.
74. Su, X., Chakravarti, D. and Flores, E.R. (2012) p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis. Nat. Rev. Cancer, 13, 136-143.
75. Levine, A.J. and Oren, M. (2009) The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer, 9, 749-758.
76. Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T. and Prives, C. (2001) A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol. Cell. Biol., 21, 1874-1887.